	Reply to 'High-dimensional overfitting and noisy diagnostic labels: reconsidering the role of BRAF copy number in primary dermal melanoma'. Br J Dermatol Zhao P, Papenfuss AT, Shackleton M. PMID: 42626950 [PubMed - as supplied by publisher]
	The ultrasound wave enhanced carbon nanotube encapsulated dacarbazine effect on melanoma cell death via ER stress-mediated apoptosis. J Educ Health Promot Mahdinejad M, Tavakoli MB, Taheri A, Hejazi H, Komeili Movahed T, Heidari F, Kermani S, Nasrollahi H. PMID: 42626724 [PubMed]
	Intrathecal immune checkpoint inhibitors as adjunctive therapy for leptomeningeal disease: A case series and systematic review. Neurosurg Rev Daftari M, Ramsoomair CK, Aka A, Himic V, Hudson A, Berckemeyer MA, Johnson M, Lu VM, Chandar J, Govindrajan V, Lutzky J, Ivan ME, Komotar RJ, Nasany R, Shah AH. PMID: 42625079 [PubMed - indexed for MEDLINE]
	Influence of metastases composition on the conspicuity of melanoma brain metastases: a comparative study of post-contrast 3D T1WI GRE versus 3D T1WI TSE black blood. Radiol Med Chen Zhou ZH, Salvador Álvarez E, Hilario A, Cárdenas A, Romero J, Lechuga C, Martínez de Aragón A, Ramos A. PMID: 42622786 [PubMed - as supplied by publisher]
	GPT Fusion: Integrating Convolutional Neural Networks with GPT-5.5 for Melanoma Diagnosis. Res Sq Frederickson KL, Li D, Adunyah SE, Wang Q. PMID: 42620269 [PubMed]
	[(99m)Tc]Tc-Tilmanocept sentinel node biopsy and long-term outcomes in melanoma: A cohort study and literature review. Eur J Surg Oncol Roshan A, Pasha T, Kounidas G, O'Leary F, Murphy S, Tajsic T, Patel AJK, Aloj L, Buscombe J, Durrani AJ. PMID: 42617582 [PubMed - as supplied by publisher]
	Systemic surveillance for uveal melanoma: Approach to optimization. PLoS One Zabor EC, Ye, Singh AD. PMID: 42616744 [PubMed - indexed for MEDLINE]
	Melanoma arising in nevus spilus: a systematic review and report of two new cases. Dermatol Reports Di Prete M, Abdollahzadeh B, Pasquini P, Ferrari A, Frascione P, Fargnoli MC, Cota C. PMID: 42615072 [PubMed - as supplied by publisher]
	MYC as a key target for melanoma therapy. Front Cell Dev Biol Lillo-Valero M, Zacarías-Fluck MF, Soucek L. PMID: 42614357 [PubMed]
	Impact of Lateral Margin Adequacy on Survival in Cutaneous Melanoma: An Asian Retrospective Cohort Study. J Dermatol Lin CY, Wu CL, Pan SC, Lee JY, Wong TW, Chang YH, Huang YH, Lu HH, Chen HHW, Liu WT. PMID: 42611550 [PubMed - as supplied by publisher]
	Clinical impact and therapeutic potential of tertiary lymphoid structures in melanoma. Front Immunol Carenza D, Bungaro C, Guida M, Apollonio B. PMID: 42609770 [PubMed - indexed for MEDLINE]
	Atypical Lentiginous Melanocytic Proliferations Case Series: Relationship to Type II Dysplastic Nevi and Lentiginous Melanoma. J Cutan Pathol Daruish M, De Ryck E, Gadeyne L, Lemahieu J, Loontiens S, Van Der Meulen J, Haspeslagh M, Bastian BC, Taibjee S. PMID: 42609158 [PubMed - as supplied by publisher]
	Low Prevalence of Hereditary Melanoma Among Patients Referred for Genetic Testing: A Multicentre Retrospective Cohort Study. J Am Acad Dermatol Bendayan E, Conte S, Lazarowitz R, Marino TC, Foulkes WD, Netchiporouk E. PMID: 42607952 [PubMed - as supplied by publisher]
	Alternative diagnostic labels for melanoma in-situ: a randomised online experiment. Br J Dermatol Bell KJL, Wu Z, Boroumand F, Parker L, Elder D, Ferguson P, O'Brien B, van Akkooi ACJ, Adamson AS, Davies E, Scolyer RA, Barnhill RL, Emery J, Low D, Low C, Nickel B. PMID: 42605178 [PubMed - as supplied by publisher]
	Assessment of the Relationship between Metabolic Activity of Uveal Melanoma in Positron Emission Tomography (PET) and Chromosome 3 Monosomy. Cesk Slov Oftalmol Mrázová K, Hecová L, Rus, Ferda J, Ferdová E, Vane. PMID: 42599796 [PubMed - indexed for MEDLINE]
	Multiple primary and familial melanoma as distinct high-risk phenotypes: a retrospective cohort study. Front Genet Carugno A, Paolino G, Valenti M, Bighetti S, Maione V, Brigenti N, Bertù L, Zerbinati N. PMID: 42598699 [PubMed]
	The CD73-adenosine axis in melanoma: from multidimensional regulation to precision immunotherapy. Front Immunol Liu X, Sun P, Chen C, Chen X. PMID: 42597984 [PubMed - indexed for MEDLINE]
	Prognostic value of different metabolic response criteria in patients with advanced melanoma treated with immunotherapy: a comparative analysis of PECRIT, PERCIMT, and EORTC criteria. Eur J Nucl Med Mol Imaging Di Giorgio A, Comito F, Bonazzi N, Battisti G, Dragonetti V, Marchese PV, Pagani R, Aprile M, Malizia C, Melotti B, Ardizzoni A, Fanti S, Nanni C. PMID: 42595801 [PubMed - as supplied by publisher]
	Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma. Clin Cancer Res Lochrin SE, Kalvin HL, Chen MF, Smithy JW, Momtaz P, Postow MA, Station S, Hochreiter C, Panageas KS, Yeh R, Barker CA, Shoushtari AN. PMID: 42594052 [PubMed - as supplied by publisher]
	Prognostic Impact of Detection Patterns, Reasons for Consultation, and Sex Differences in Melanoma Among Young Adults: A 30-Year Retrospective Cohort Study. Int J Dermatol Rodríguez-Sánchez B, Avilés-Izquierdo JA, Martín-Nieto-González J, de la Puente-Alonso M, Zamarro-Díaz L, Fuentes-Bellas A, de Ramón-Rueda D, Jiménez-Briones L, Rodríguez-Lomba E, Arias-Lotto F, de la Cueva-Dobao P. PMID: 42592703 [PubMed - as supplied by publisher]

Articles 1 - 20 / 46150

Page 1 of 2308



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy